tiprankstipranks
Ohki Health Care Holdings, Inc. (JP:3417)
:3417
Japanese Market

Ohki Health Care Holdings, Inc. (3417) AI Stock Analysis

0 Followers

Top Page

JP:3417

Ohki Health Care Holdings, Inc.

(3417)

Select Model
Select Model
Select Model
Neutral 50 (OpenAI - 5.2)
Rating:50Neutral
Price Target:
¥1,340.00
▼(-5.77% Downside)
Action:ReiteratedDate:03/24/26
The score is held back primarily by weak and volatile cash flow (including sharply negative FY2025 operating and free cash flow) alongside higher leverage, despite steady revenue growth and positive earnings. Technical signals also lean bearish (below key moving averages with negative MACD). A reasonable P/E and modest dividend yield provide partial offset.
Positive Factors
Consistent revenue growth
Sustained top-line growth, accelerating to +10% in FY2025, indicates durable demand for distribution services and expanding volume. Over 2–6 months this underpins stable order flow and revenue visibility, supporting operational scale and bargaining power with suppliers.
Negative Factors
Volatile cash generation
Sharp reversal to deeply negative operating and free cash flow raises persistent funding risk: working-capital swings or one-time outflows can overwhelm earnings. Over months this can force reliance on external financing, constrain investment, and pressure liquidity management.
Read all positive and negative factors
Positive Factors
Negative Factors
Consistent revenue growth
Sustained top-line growth, accelerating to +10% in FY2025, indicates durable demand for distribution services and expanding volume. Over 2–6 months this underpins stable order flow and revenue visibility, supporting operational scale and bargaining power with suppliers.
Read all positive factors

Ohki Health Care Holdings, Inc. (3417) vs. iShares MSCI Japan ETF (EWJ)

Ohki Health Care Holdings, Inc. Business Overview & Revenue Model

Company Description
Ohki Healthcare Holdings Co.,Ltd. distributes pharmaceutical products, health foods, dairy products, cosmetics, and daily necessities. The company imports, exports, and sells pharmaceuticals, quasi-drugs, medical equipment, cosmetics, poisons and ...
How the Company Makes Money
null...

Ohki Health Care Holdings, Inc. Financial Statement Overview

Summary
Steady revenue growth and positive earnings are offset by very thin profitability (FY2025 gross margin ~5.2%, net margin ~0.8%) and a major deterioration in cash generation. FY2025 operating cash flow and free cash flow were deeply negative (-9.2B and -12.0B), and leverage increased (debt-to-equity ~0.46), raising funding and liquidity risk if weak cash flow persists.
Income Statement
62
Positive
Balance Sheet
66
Positive
Cash Flow
35
Negative
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue352.90B349.45B334.66B304.44B278.16B270.93B
Gross Profit19.01B18.19B16.89B15.58B13.42B15.20B
EBITDA3.45B3.16B2.42B2.44B981.00M3.34B
Net Income2.83B2.64B2.21B2.18B971.00M2.75B
Balance Sheet
Total Assets141.50B140.96B140.08B123.96B115.39B112.28B
Cash, Cash Equivalents and Short-Term Investments3.49B2.88B8.31B3.24B2.77B2.80B
Total Debt13.41B14.21B6.95B8.48B7.50B8.61B
Total Liabilities110.48B109.90B112.18B99.68B93.29B90.14B
Stockholders Equity30.96B30.99B27.84B24.13B21.95B21.93B
Cash Flow
Free Cash Flow0.00-12.03B7.27B-138.00M1.22B-4.40B
Operating Cash Flow0.00-9.18B7.55B96.00M1.31B-4.27B
Investing Cash Flow0.00-3.13B-496.00M-291.00M68.00M710.00M
Financing Cash Flow0.006.89B-2.00B681.00M-1.40B2.36B

Ohki Health Care Holdings, Inc. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price1422.00
Price Trends
50DMA
1341.49
Positive
100DMA
1366.60
Negative
200DMA
1306.65
Positive
Market Momentum
MACD
7.73
Negative
RSI
52.12
Neutral
STOCH
58.36
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3417, the sentiment is Positive. The current price of 1422 is above the 20-day moving average (MA) of 1339.25, above the 50-day MA of 1341.49, and above the 200-day MA of 1306.65, indicating a bullish trend. The MACD of 7.73 indicates Negative momentum. The RSI at 52.12 is Neutral, neither overbought nor oversold. The STOCH value of 58.36 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:3417.

Ohki Health Care Holdings, Inc. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
¥210.52B12.712.35%7.55%16.01%
67
Neutral
¥357.89B16.820.41%15.81%27.05%
66
Neutral
¥665.13B14.4415.71%0.96%21.81%67.76%
62
Neutral
¥979.56B19.411.72%
60
Neutral
¥511.03B22.790.93%3.73%18.84%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
50
Neutral
¥18.65B14.561.83%4.30%52.38%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:3417
Ohki Health Care Holdings, Inc.
1,352.00
632.30
87.86%
JP:7649
Sugi Holdings Co
3,529.00
438.57
14.19%
JP:3391
TSURUHA Holdings
2,177.50
-3.89
-0.18%
JP:3148
Create SD Holdings Co., Ltd.
3,330.00
434.79
15.02%
JP:3349
COSMOS Pharmaceutical Corporation
6,420.00
-1,705.32
-20.99%
JP:3549
KUSURI NO AOKI HOLDINGS CO.,LTD.
3,743.00
472.22
14.44%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 24, 2026